Vomiting is a Potential Adverse Drug Reaction for Levomilnacipran

@inproceedings{Sarkar2017VomitingIA,
  title={Vomiting is a Potential Adverse Drug Reaction for Levomilnacipran},
  author={Atreyee Sarkar and Shivanand Dhanure},
  year={2017}
}
Levomilnacipran is a drug used to treat depression. Micro Labs is a generic drug company which had developed an extended release formulation of Levomilnacipran 120 mg capsule. Two studies were conducted to assess the safety, tolerability and bioequivalence of the extended release formulation of 120 mg Levomilnacipran capsules. A total of 42 subjects had been included for each of the fasting and fed studies. Out of them, 30 subjects completed the fasting study and 28 subjects completed the fed… CONTINUE READING